A Smart Self-Management Support Programme (3S) to Improve Quality of Life in Lung Cancer Patients
A Smart Self-Management Support Programme (3S) to Improve Quality of Life in Patients With Lung Cancer - A Pragmatic Randomized Controlled Trial With Mixed-method Evaluation
The University of Hong Kong
320 participants
Apr 22, 2024
INTERVENTIONAL
Conditions
Summary
Lung cancers patients often experience multiple symptoms (e.g. fatigue, dyspnea, distress, depression, sleep disturbance). The current study attempts to explore the efficacy of the Smart Self-Management Support Programme (3S) in improving quality of life of patients using self-management support programme with mobile devices.
Eligibility
Inclusion Criteria11
- Patients:
- Aged 18 years or above
- Diagnosis of advanced-stage (stage III or stage IV) non-small cell lung cancer
- Ambulatory and capable of all self-care activities (ECOG ≤2)
- Either undergoing or has finished oncology therapy
- Mentally, cognitively and physically fit to join as determined by the doctor in charge and responsible clinical investigators
- Can speak and read Chinese
- Willing to complete the patient-reported outcome questionnaire
- Has a smartphone with WhatsApp or WeChat
- Aged 18 years or above
- Family caregivers of recruited patients
Exclusion Criteria11
- Preparing for lung operation
- Skeletal fragility
- Serious active infection
- Inability to walk
- Previously untreated symptomatic brain metastases
- Severe respiratory insufficiency
- Uncontrolled pain
- Diagnosed psychiatric illness with or without medication
- Family Caregivers:
- Unable to speak and read Chinese
- Unwilling to complete the patient-reported outcome questionnaire
Interventions
The 3S intervention includes information and support related to self-management of lung cancer, including 1. an individual 3S session at baseline, 2. 24-week messaging, telephone coaching and hotline services.
The GH information includes information related to general health, including 1. an individual GH session at baseline, 2. 24-week messaging, telephone coaching and hotline services.
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06377124